Lupin gains on receiving EIR from USFDA for New Jersey facility 0 24.06.2024 08:02 Business Standard Lupin rose 1.11% to Rs 1,577 after the company announced that it has received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility in Somerset at New Jersey. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
